Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Indexed in the following public directories
Overview | |
Publisher | DOVE MEDICAL PRESS LTD |
Language | English |
Frequency | Continuous publication |
Article Processing Charges | USD 2390 |
Publication Time | 16 |
Editorial Review Process | Anonymous peer review |
General Details | |
Language | English |
Frequency | Continuous publication |
Publication Start Year | 2011 |
Publisher URL | Visit website |
Website URL | Visit website |
Publication Details | |
Plagiarism | Visit website |
Waiver Policy | Visit website |
Publication Time | 16 |
Article Processing Charges | USD 2390 |
Editorial Review Detail | |
Editorial Team | Visit website |
Review Process | Anonymous peer review |
Review Url | Visit website |
Information for authors | |
Author instructions | Visit website |
Copyright Details | Visit website |
Deposit Policy | Sherpa/Romeo |
License type | CC BY, CC BY-NC |
OA statement | Visit website |
Upload your Manuscript to get
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my Paper147 articles received 1.9k citations see all
PSORIASIS-TARGETS AND THERAPY has been in operation since 2011 till date.
PSORIASIS-TARGETS AND THERAPY published with a Continuous publication frequency.
In 2023, PSORIASIS-TARGETS AND THERAPY published 7 articles.
For PSORIASIS-TARGETS AND THERAPY,eISSN is 2230-326X and pISSN is2230-326X.
DOVE MEDICAL PRESS LTD is the publisher of PSORIASIS-TARGETS AND THERAPY.